Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1651 1653 1654 1656 1657 1799
This examiner grants 38% of resolved cases
Georgiana C. Reglas serves as an examiner in Tech Center 1700 and Art Unit 1651. He has a total of 77 resolved cases. The allowance rate for these cases is 37.7 percent. This 37.7 percent rate indicates the frequency at which applications reach a grant under his review. With 77 resolved cases, the profile provides a specific look at the outcomes in this docket.
The interview lift is 36.1 percent. This 36.1 percent figure is lower than the 37.7 percent allowance rate, but it represents a significant increase in the likelihood of allowance for cases that include an interview. Practitioners in Art Unit 1651 may use this 36.1 percent lift to evaluate the impact of direct communication. The median days to allowance is 1342. This 1342-day duration is the typical timeframe for successful applications. The 1342-day metric, combined with the 77 resolved cases, helps stakeholders understand the pendency and probability of success in Tech Center 1700.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17765960 | PURIFICATION OF PROTEINS AND VIRAL INACTIVATION | Final Rejection | MERCK PATENT GMBH |
| 18347733 | METHOD FOR SELECTING CELLS, APPARATUS, AND APPARATUS SYSTEM | Non-Final OA | FUJIFILM Corporation |
| 18242009 | WASHING AND CLEANING AGENT COMPRISING TANNASE II | Final Rejection | Henkel AG & Co. KGaA |
| 18729410 | METHOD OF ENZYMATIC CLEANING TO REMOVE MICROORGANISMS OR BIOFILM FROM INDUSTRIAL EQUIPMENT | Non-Final OA | ECOLAB USA INC. |
| 17558186 | FUNCTIONAL COMPOSITE MEMBRANES FOR CHROMATOGRAPHY AND CATALYSIS | Final Rejection | California Institute of Technology |
| 18585375 | TRANSCRIPTION TERMINATOR BIOPARTS BASED ON 3'-UNTRANSLATED REGION (UTR) AND A METABOLIC ENGINEERING METHOD THEREOF | Non-Final OA | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 17058891 | TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR | Non-Final OA | Purdue Research Foundation |
| 17442776 | PROBIOTIC BACTERIA CAPABLE OF ADAPTIVE RESPONSE TO POMEGRANATE EXTRACT AND METHODS OF PRODUCTION AND USE THEREOF | Non-Final OA | North Carolina State University |
| 18547468 | METHODS FOR LIGATION OF (POLY)PEPTIDES AND OLIGONUCLEOTIDES | Final Rejection | Nanyang Technological University |
| 18262523 | DETECTING BETA-LACTAMASE ENZYME ACTIVITY | Final Rejection | UNIVERSITE PARIS-SACLAY |
| 18579070 | ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING HYDROCARBON CHAINS | Non-Final OA | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY |
| 18206830 | METHOD FOR TREATING CANCER | Non-Final OA | The Children's Medical Center Corporation |
| 17621497 | RATIOMETRIC DETECTION OF LUCIFERASE ASSAYS USING A CALIBRATOR LUCIFERASE | Final Rejection | TECHNISCHE UNIVERSITEIT EINDHOVEN |
| 17626168 | METHODS FOR MAKING RECOMBINANT PROTEIN | Final Rejection | Monash University |
| 18056629 | ENGINEERED AND CHIMERIC NUCLEASES | Non-Final OA | Metagenomi Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy